Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development
15 août 2023 07h00 HE
|
Parexel International LLC
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets ...
Parexel Announces Updates to Board of Directors
23 juin 2023 08h49 HE
|
Parexel International LLC
Goldman Sachs’ Partner, Global co-Head of Private Equity Michael Bruun joins as new Director, succeeding current Goldman Sachs Board member Jo Natauri who is retiring from the firm at the end of the...
Parexel Rated “Top CRO to Work With” in 2023 WCG CenterWatch Global Site Relationship Benchmark Survey for Second Straight Time
31 mai 2023 09h00 HE
|
Parexel International LLC
DURHAM, N.C., May 31, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Appoints Scott Smith, M.D., Ph.D. as New Head of Hematology
19 avr. 2023 09h00 HE
|
Parexel International LLC
DURHAM, N.C., April 19, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Introduces Expert Series – New Medicines, Novel Insights
28 févr. 2023 09h00 HE
|
Parexel International LLC
DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Teams with MyEyeDr. to Increase Patient Access and Participation in Ophthalmology Clinical Trials
15 déc. 2022 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
Parexel Announces Significant Recognition for Diversity and Workplace Culture in Asia/Pacific Region; Reaches Significant Company Milestone in Japan
29 nov. 2022 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
27 sept. 2022 16h30 HE
|
Parexel International LLC
New depot offers local and international biopharmaceutical customers timely access to supplies and medications for clinical trial sites and patientsto accelerate clinical trials in the region BOSTON...
Parexel’s Peyton Howell Awarded Prestigious PharmaVoice Red Jacket
15 sept. 2022 16h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Appoints Peyton Howell Chief Operating and Growth Officer; Promotes FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence
14 sept. 2022 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the promotions of Peyton Howell to the newly-created role...